Seneca House Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.87M | Sell |
9,549
-340
| -3% | -$138K | 1.65% | 18 |
|
|
2025
Q1 | $4.92M | Sell |
9,889
-285
| -3% | -$142K | 2.09% | 18 |
|
|
2024
Q4 | $5.29M | Buy |
10,174
+595
| +6% | +$310K | 2.1% | 17 |
|
|
2024
Q3 | $5.93M | Sell |
9,579
-45
| -0.5% | -$27.8K | 2.5% | 17 |
|
|
2024
Q2 | $5.32M | Buy |
9,624
+37
| +0.4% | +$20.5K | 2.31% | 20 |
|
|
2024
Q1 | $5.57M | Sell |
9,587
-108
| -1% | -$62.8K | 2.42% | 20 |
|
|
2023
Q4 | $5.15M | Buy |
9,695
+182
| +2% | +$96.6K | 2.38% | 19 |
|
|
2023
Q3 | $4.72M | Buy |
9,513
+1,099
| +13% | +$545K | 2.46% | 19 |
|
|
2023
Q2 | $4.39M | Buy |
8,414
+1,521
| +22% | +$794K | 2.19% | 20 |
|
|
2023
Q1 | $3.97M | Sell |
6,893
-229
| -3% | -$132K | 2.06% | 20 |
|
|
2022
Q4 | $3.92M | Buy |
7,122
+4,083
| +134% | +$2.25M | 2.17% | 16 |
|
|
2022
Q3 | $1.54M | Buy |
3,039
+186
| +7% | +$94.3K | 1.14% | 29 |
|
|
2022
Q2 | $1.55M | Sell |
2,853
-13
| -0.5% | -$7.06K | 1.01% | 31 |
|
|
2022
Q1 | $1.69M | Buy |
2,866
+312
| +12% | +$184K | 0.89% | 31 |
|
|
2021
Q4 | $1.7M | Buy |
2,554
+536
| +27% | +$358K | 0.9% | 30 |
|
|
2021
Q3 | $1.15M | Buy |
+2,018
| New | +$1.15M | 0.69% | 32 |
|